My issue with the subjective reporting of pain as being a primary end point is that there are a lot of reasons people are motivated to lie about their level of back pain. Compensation claims which depend on on-going pain - or drug addicts that purport to be in pain to continue obtaining opioid medications.
For me the key outcome is the 40% reduction in opioid use in the treated cohort, this is hard to look past.
Sentiment changed to buy and we'll see if I change to Hold after the opening auction.
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results, page-53
-
- There are more pages in this discussion • 1,051 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
0.000(0.00%) |
Mkt cap ! $1.609B | |||
| Open | High | Low | Value | Volume |
| $1.44 | $1.46 | $1.40 | $2.885M | 2.022M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 29484 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 52302 | 12 |
View Market Depth
| Last trade - 14.59pm 15/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |